Model
Edge
Mirati Therapeutics Inc.
MRTX
Filing type
8-K
Filing date
Jan 22, 2024
Updated
Jan 23, 2024 ยท 1:48 AM
Copy reference
Filing
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
Exhibits
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2
EX-99.1
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events